ECBK vs EBS: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

EBS has stronger fundamentals based on our AI analysis.

ECBK
ECB Bancorp, Inc. /MD/
HOLD
42%
Confidence
VS
EBS
Emergent BioSolutions Inc.
BUY
72%
Confidence

ECBK vs EBS Fundamental Comparison

Metric ECBK EBS
Revenue $57.1M $742.9M
Net Income $5.2M $52.6M
Net Margin 9.1% 7.1%
ROE 3.1% 10.1%
ROA 0.3% 4.0%
Current Ratio N/A 5.01x
Debt/Equity 0.00x 1.13x
EPS $0.62 $0.93

Green = Better metric | Red = Weaker metric

View Full ECBK Analysis →
View Full EBS Analysis →

You Might Also Compare

ECBK vs AAPL EBS vs MSFT ECBK vs GOOGL EBS vs AMZN

ECBK vs EBS: Frequently Asked Questions

Is ECBK or EBS a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), EBS has stronger fundamentals. ECBK is rated HOLD (42% confidence) while EBS is rated BUY (72% confidence). This is not investment advice.

How does ECBK compare to EBS fundamentally?

ECB Bancorp, Inc. /MD/ has ROE of 3.1% vs Emergent BioSolutions Inc.'s 10.1%. Net margins are 9.1% vs 7.1% respectively.

Which stock pays higher dividends, ECBK or EBS?

ECBK has a dividend yield of N/A or no dividend while EBS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ECBK or EBS for long term?

For long-term investing, consider that ECBK has HOLD rating with 42% confidence, while EBS has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ECBK vs EBS?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ECBK vs EBS, the AI consensus favors EBS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.